Literature DB >> 18480825

Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip.

J Svartberg1, I Agledahl, Y Figenschau, T Sildnes, K Waterloo, R Jorde.   

Abstract

Our intention was to examine if subnormal testosterone levels in older men were associated with a reduction in quality of life and physical and mental health, and secondly to examine if testosterone treatment could improve these conditions. We performed a nested case-control study and a 1-year testosterone intervention study. Men with subnormal testosterone had significantly higher weight, fat mass and abdominal adipose tissue. They also had significantly higher glucose and insulin levels, and they had higher triglyceride levels. Testosterone treatment had a large impact on body composition with reduced fat mass and abdominal adipose tissue and increased fat-free mass, but it did not affect weight and glucose and lipid metabolism. Bone mineral density in the hip was significantly higher after the testosterone treatment. Older men with subnormal testosterone levels had an unfavorable metabolic profile. Testosterone treatment improved body composition, but it did not reverse the unfavorable metabolic profile.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480825     DOI: 10.1038/ijir.2008.19

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  43 in total

Review 1.  Androgens and male aging: Current evidence of safety and efficacy.

Authors:  Louis J Gooren
Journal:  Asian J Androl       Date:  2010-02-15       Impact factor: 3.285

2.  An update on male hypogonadism therapy.

Authors:  Prasanth Surampudi; Ronald S Swerdloff; Christina Wang
Journal:  Expert Opin Pharmacother       Date:  2014-04-23       Impact factor: 3.889

Review 3.  Subcutaneous fat loss is greater than visceral fat loss with diet and exercise, weight-loss promoting drugs and bariatric surgery: a critical review and meta-analysis.

Authors:  C Merlotti; V Ceriani; A Morabito; A E Pontiroli
Journal:  Int J Obes (Lond)       Date:  2017-02-02       Impact factor: 5.095

4.  Aging and exercise training reduce testes microvascular PO2 and alter vasoconstrictor responsiveness in testicular arterioles.

Authors:  James M Dominguez; Robert T Davis; Danielle J McCullough; John N Stabley; Bradley J Behnke
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

Review 5.  Mitochondrial adaptations evoked with exercise are associated with a reduction in age-induced testicular atrophy in Fischer-344 rats.

Authors:  A-M Joseph; L M-D Nguyen; A E Welter; J M Dominguez; B J Behnke; P J Adhihetty
Journal:  Biogerontology       Date:  2014-08-10       Impact factor: 4.277

6.  Testosterone therapy increased muscle mass and lipid oxidation in aging men.

Authors:  Louise Frederiksen; Kurt Højlund; David M Hougaard; Kim Brixen; Marianne Andersen
Journal:  Age (Dordr)       Date:  2011-02-24

Review 7.  Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.

Authors:  Stephen E Borst; Joshua F Yarrow
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-04-21       Impact factor: 4.310

8.  The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.

Authors:  Farid Saad; Louis J Gooren
Journal:  J Obes       Date:  2010-08-10

Review 9.  The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease.

Authors:  Abdulmaged M Traish; Michael Zitzmann
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

10.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.